ACXP vs CFG · $11.3M cap vs P/E 15, rev $2.28B
Acurx Pharmaceuticals LLC (ACXP) versus Citizens Financial Group, Inc. (CFG) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Citizens Financial Group, Inc. (CFG) is a banks - regional company listed on US.
ACXP does not have a complete income-statement cache yet.
Latest reported CFG revenue for 2026-06-30 was $2.28B. Net income was $587.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
ACXP currently screens at market cap $11.3M. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
Not investment advice. Open the ACXP and CFG stock pages for the full models.
Not investment advice.